The PLOD3 gene helps your body build and strengthen collagen, a key support material in skin, bones, blood vessels, and other tissues. When this gene is not working properly, connective tissue can be weaker than usual, which may lead to fragile skin, joint looseness, vision problems, bone changes, or blood vessel complications. Pathogenic variants in the PLOD3 gene are linked to a rare inherited connective tissue condition, and the effects can vary from person to person.
What is a gene?
Genes are segments of DNA that provide cells with instructions for making molecules or regulating processes in the body. Some genes hold the information needed to make proteins, the parts of cells that do the work. Other genes mainly control when certain processes happen, where they happen, and how strongly they run. Taken together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. You can find more on this topic in the LearnHub.
Overview
PLOD3Gene function
What if the gene works
The PLOD3 gene helps cells finish making collagen, a key protein that gives support to skin, blood vessels, bones, and other tissues. Its protein adds small chemical tags to collagen so connective tissues can form and stay strong.
Risk
What if the gene does not work
More disruptive variants in the PLOD3 gene can cause a connective tissue condition with fragile skin, bruising, joint and bone problems, and eye or hearing changes. Milder variants may lead to later onset or a less broad pattern of features.
Treatment
What does that mean for your treatment
No PLOD3-specific treatment or drug choice is currently established for people with a pathogenic variant in the PLOD3 gene. Care is supportive and guided by a person’s symptoms rather than by a medicine selected because of the PLOD3 gene. The PLOD3 gene is also being studied in cancer and tissue-scarring research as a possible biomarker or drug target, but this has not led to guideline-based treatment use.
Conditions associated with PLOD3
Gene function
What if the gene works
PLOD3 helps your body build sturdy collagen, the main support protein in connective tissue. This matters in structures that need both strength and flexibility, including skin, blood vessels, cartilage, and the thin support layers around organs. Understanding how the PLOD3 gene works in the body helps explain everyday tissue strength and support.
PLOD3 helps cells prepare collagen before it is built into tissues. It modifies selected lysine building blocks, which helps collagen mature and form stable links.
Its protein adds small sugar groups to certain prepared spots on collagen. These finishing steps help collagen fibers fit into the surrounding tissue framework.
By shaping collagen in these ways, PLOD3 supports the extracellular matrix (the material around cells that gives tissues support). This helps many organs keep their structure and helps thin support layers stay organized.
What is a variant?
A genetic variant is a small difference in the DNA sequence within a gene. These changes are common and are part of normal human diversity, such as differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and simply reflect natural genetic variation. In some situations, though, a variant can change how a gene functions to a greater extent and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the PLOD3 gene can change the protein’s shape, stability, or enzyme activity, which may disrupt collagen processing inside cells. This helps explain how PLOD3 gene variants affect collagen processing: milder variants may leave some protein activity, while more severe variants can lead to very little or no working protein. In people with PLOD3-related conditions, that functional range can influence how early features appear and how extensive they are.
How variants are linked to conditions
Variants in the PLOD3 gene are linked to a rare inherited connective tissue condition called PLOD3-related connective tissue disorder. People with this diagnosis may have fragile bones, loose joints, vision or hearing changes, and sometimes blood vessel problems such as aneurysms (bulges in a blood vessel wall). Some also have short stature, cleft palate, or skin that bruises easily. Finding pathogenic variants in both copies of the PLOD3 gene can confirm the diagnosis.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are common across the general population. Most do not have a direct effect on health and instead represent natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well-characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For PLOD3, risk is mainly shaped by genetics rather than lifestyle. The chance of having a PLOD3-related condition is higher when both parents carry a disease-causing change in the PLOD3 gene, so family history and parents being blood relatives can increase the chance in a child.
Inheritance of PLOD3 variants
PLOD3-related conditions are inherited in an autosomal recessive pattern. This means a person usually develops the condition only when they inherit two disease-causing variants in the PLOD3 gene, one from each parent. Parents who each carry one variant are typically unaffected carriers, and with each pregnancy they have a 25% chance of having an affected child, a 50% chance of having a child who is a carrier, and a 25% chance of having a child with neither variant. In families asking about inheritance of PLOD3 gene variants, this also means carriers can pass the variant to sons and daughters equally.
What does my PLOD3 result mean for my family?
For families with a disease-causing PLOD3 result linked to the known PLOD3-related condition, the pattern is recessive, which usually means parents are healthy carriers and brothers or sisters may also be affected or be carriers. Close relatives may want to learn whether the same gene change runs in the family, especially if there is a history of joint problems, vision or hearing changes, or fragile tissues. Children of an affected person are usually carriers unless the other parent also carries a PLOD3 change.
Genetic information
Genetic testing
How you find out about variants
To look for variants in the PLOD3 gene, clinicians use genetic testing on a blood or saliva sample. PLOD3 genetic testing reads your DNA to check for changes that may help confirm a genetic cause of symptoms. Results may identify a pathogenic variant, a benign variant, or a variant of uncertain significance.
When should I consider getting a genetic test?
Genetic testing for the PLOD3 gene may be considered when someone has signs of a rare inherited connective tissue condition, especially a mix of very flexible joints, fragile bones, eye or hearing problems, and blood vessel concerns. It can also help when these features run in the family or when a child has several of them from an early age.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it reveals depends on the condition and the specific type of variant. Over time, many factors shape how the body works, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put personal experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Small differences in genes can change how a drug is broken down, how strongly it works, or how sensitive you are to side effects. This helps explain why the same treatment can work well for one person, seem less effective for another, or cause more unwanted effects in someone else.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect the way a person responds to medications. By looking at relationships between genes and drugs, it helps explain why the same treatment may work differently in different people. For many medicines, genes can influence both how strongly a drug works and how the body processes it. This information can support treatment decisions that are more informed and more individualized. More on this topic is available in the LearnHub.
Drugs influenced by the PLOD3 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication response, so any concerns about medicines, side effects, or new health changes are best discussed with your doctor.